StockData
Xencor Inc logo

Xencor Inc (XNCR) stock

XNCRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30194% above fair value
$34.39−0.11 (-0.32%)

Close on Nov 18, 2026Market cap $2.56BP/E –Yield –

Xencor price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Xencor's price to book ratio was 5.9× on Nov 11, 2026, against 2.0× a year earlier. Over the last 5 years it ranged from 0.9× to 5.9×, with a median of 2.1×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20265.9×+4.2
2025Dec 31, 20251.7×−0.5
2024Dec 31, 20242.3×+0.3
2023Dec 29, 20231.9×−0.2
2022Dec 30, 20222.2×−1.6
2021Dec 31, 20213.8×−0.6
2020Dec 31, 20204.4×+1.2
2019Dec 31, 20193.2×−0.6
2018Dec 31, 20183.8×+0.3
2017Dec 29, 20173.5×−1.8
2016Dec 30, 20165.3×+1.5
2015Dec 31, 20153.9×−4.6
2014Dec 31, 20148.4×–

More Xencor figures

See a number that looks wrong?